Literature DB >> 21693607

The impact of the severity of vision loss on vision-related quality of life in India: an evaluation of the IND-VFQ-33.

Robert P Finger1, David G Kupitz, Frank G Holz, Bharath Balasubramaniam, Ramanathan V Ramani, Ecosse L Lamoureux, Eva Fenwick.   

Abstract

PURPOSE: To validate the 33-item Indian Vision Functioning Questionnaire (IND-VFQ-33), a vision-specific scale, and determine the relationship between the severity of vision impairment (VI) and vision-related quality of life (VRQoL).
METHODS: In this cross-sectional, observational study 273 participants with VI from cataract were recruited from a South Indian eye hospital. Participants underwent a clinical examination and completed the IND-VFQ-33 scale. The psychometric properties of the IND-VFQ-33 and its subscales were assessed using Rasch analysis, exploring key indices such as instrument unidimensionality, discriminant ability, and targeting of item difficulty to patient ability.
RESULTS: Rasch analysis demonstrated the validity of the IND-VFQ-33 to assess VRQoL through four subscales (i.e., vision-specific mobility, activity limitation, psychosocial impact, and visual symptoms), but not as an overall measure. In adjusted multivariate analysis models, those with severe VI and blindness reported significantly poorer vision-specific mobility and activity limitation (mean change, -18.82, P = 0.007 and -29.48, P < 0.001, respectively) compared with those with no VI. These decrements in vision-specific functioning were both clinically significant. Lack of schooling and schooling up to completion of primary school were associated with poorer vision-specific mobility and visual symptoms, respectively.
CONCLUSIONS: Using a psychometrically valid IND-VFQ, only severe VI and blindness led to a clinically meaningful decline in vision-specific mobility and activity limitation. This finding reflects the current protocol for cataract surgery referral in developing or transitional countries, where priority is given to patients with at least moderate to severe VI.

Entities:  

Mesh:

Year:  2011        PMID: 21693607     DOI: 10.1167/iovs.11-7388

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  16 in total

1.  Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.

Authors:  Jennifer Rose-Nussbaumer; N Venkatesh Prajna; K Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Muthiah Srinivasan; Anita Raghavan; Catherine E Oldenburg; Kieran S O'Brien; Kathryn J Ray; Stephen D McLeod; Travis C Porco; Thomas M Lietman; Nisha R Acharya; Jeremy D Keenan
Journal:  JAMA Ophthalmol       Date:  2015-06       Impact factor: 7.389

2.  Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.

Authors:  Jennifer Rose-Nussbaumer; N Venkatesh Prajna; Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Muthiah Srinivasan; Anita Raghavan; Catherine E Oldenburg; Kieran S O'Brien; Kathryn J Ray; Travis C Porco; Stephen D McLeod; Nisha R Acharya; Jeremy D Keenan; Thomas M Lietman
Journal:  Br J Ophthalmol       Date:  2015-11-03       Impact factor: 4.638

3.  Evaluation of item candidates for a diabetic retinopathy quality of life item bank.

Authors:  Eva K Fenwick; Konrad Pesudovs; Jyoti Khadka; Gwyn Rees; Tien Y Wong; Ecosse L Lamoureux
Journal:  Qual Life Res       Date:  2012-11-08       Impact factor: 4.147

4.  Psychometric Assessment of the Chinese Version of the Indian Vision Functioning Questionnaire Based on the Method of Successive Dichotomizations.

Authors:  Rongrong Gao; Sisi Chen; Shixiang Yan; Tianhao Lu; Haisi Chen; Qi Feng; Qinmei Wang; Yong Sun; Jinhai Huang; Jyoti Khadka
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

5.  Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis.

Authors:  Nicole K Kelly; Aheli Chattopadhyay; S R Rathinam; John A Gonzales; Radhika Thundikandy; Anuradha Kanakath; S Bala Murugan; R Vedhanayaki; Dean Cugley; Lyndell L Lim; Eric B Suhler; Hassan A Al-Dhibi; Caleb D Ebert; Elyse J Berlinberg; Travis C Porco; Nisha R Acharya
Journal:  Ophthalmology       Date:  2021-03-04       Impact factor: 14.277

6.  Coping strategy in persons with low vision or blindness - an exploratory study.

Authors:  Puja Rai; Jolly Rohatgi; Upreet Dhaliwal
Journal:  Indian J Ophthalmol       Date:  2019-05       Impact factor: 1.848

7.  The impact of successful cataract surgery on quality of life, household income and social status in South India.

Authors:  Robert P Finger; David G Kupitz; Eva Fenwick; Bharath Balasubramaniam; Ramanathan V Ramani; Frank G Holz; Clare E Gilbert
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

8.  Impact of initial topical medical therapy on short-term quality of life in newly diagnosed patients with primary glaucoma.

Authors:  Vishal Arora; Shveta Jindal Bali; Sanjeev Kumar Gupta; Praveen Vashisht; Tushar Agarwal; Vishnubhatla Sreenivas; Tanuj Dada
Journal:  Indian J Ophthalmol       Date:  2015-06       Impact factor: 1.848

9.  Results of cataract surgery in the very elderly population.

Authors:  Katarzyna Michalska-Małecka; Mariusz Nowak; Piotr Gościniewicz; Jacek Karpe; Ludmiła Słowińska-Łożyńska; Agnieszka Łypaczewska; Dorota Romaniuk
Journal:  Clin Interv Aging       Date:  2013-08-07       Impact factor: 4.458

10.  Development of a rapid point-of-care patient reported outcome measure for cataract surgery in India.

Authors:  Joshua R Ehrlich; Charlie Frank; Josiah Smiley; Hong-Gam Le; Sanil Joseph; Stephen G Schilling; Brian C Stagg; Joshua D Stein; R D Ravindran; Aravind Haripriya
Journal:  Health Qual Life Outcomes       Date:  2018-01-30       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.